Irrisept in Emergency General Surgery Patients
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER · Jun 29, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients (\>18 years old at time of enrollment) who are hospitalized at UT Tyler and undergo an open (or conversion to open) wound class 2-4 surgical procedure for an emergent surgical condition.
- Exclusion Criteria:
- • Those \<18 years of age
- • Pressure wounds
- • Superficial abscesses (as primary diagnosis)
- • intra-abdominal abscess due to previous technical failure
About The University Of Texas Health Science Center At Tyler
The University of Texas Health Science Center at Tyler is a leading academic institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent sponsor of clinical trials, the center focuses on translating scientific discoveries into effective treatments and interventions, fostering collaborations among researchers, healthcare professionals, and industry partners. With a commitment to improving patient outcomes and addressing pressing health challenges, the university emphasizes rigorous ethical standards and robust methodologies in its research initiatives, striving to enhance the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tyler, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported